We are live on ! Find out more
PC

Pier Capital Portfolio holdings

AUM $755M
1-Year Est. Return 94.38%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$948M
AUM Growth
-$16.6M
Cap. Flow
-$2.68M
Cap. Flow %
-0.28%
Top 10 Hldgs %
15.72%
Holding
131
New
12
Increased
58
Reduced
42
Closed
19

Top Buys

Rank Stock Value
1
FLNC icon
Fluence Energy
FLNC
+$12.5M
2
FROG icon
JFrog
FROG
+$12.1M
3
BROS icon
Dutch Bros
BROS
+$10.9M
4
HQY icon
HealthEquity
HQY
+$10.2M
5
BE icon
Bloom Energy
BE
+$9.86M

Sector Composition

Rank Sector Weight
1 Technology 30.63%
2 Healthcare 21.81%
3 Industrials 15.72%
4 Consumer Discretionary 14.16%
5 Consumer Staples 5.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MC icon
76
Moelis & Co
MC
$4.91B
$6.62M 0.7%
105,975
-81,006
-43% -$5.43M
SPT icon
77
Sprout Social
SPT
$579M
$6.54M 0.69%
72,120
+377
+0.5% +$42.7K
ALXO icon
78
ALX Oncology
ALXO
$278M
$6.47M 0.68%
301,203
+225,841
+300% +$9.74M
IBP icon
79
Installed Building Products
IBP
$6.46B
$6.33M 0.67%
45,282
+278
+0.6% +$35.6K
ALEC icon
80
Alector
ALEC
$228M
$6.32M 0.67%
305,921
-615
-0.2% -$13.9K
EVBG
81
DELISTED
Everbridge, Inc. Common Stock
EVBG
$6.31M 0.67%
93,777
+38,758
+70% +$4.69M
PGNY icon
82
Progyny
PGNY
$1.99B
$6.21M 0.66%
123,410
-359
-0.3% -$20.1K
CDMO
83
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$5.76M 0.61%
197,565
-163,722
-45% -$4.69M
SGRY icon
84
Surgery Partners
SGRY
$2.01B
$5.57M 0.59%
+104,363
New +$4.84M
SDIG
85
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$5.54M 0.58%
+43,083
New +$9.01M
ADPT icon
86
Adaptive Biotechnologies
ADPT
$3.89B
$5.51M 0.58%
196,302
-1,190
-0.6% -$36.5K
BLFS icon
87
BioLife Solutions
BLFS
$1.72B
$5.3M 0.56%
142,342
-534
-0.4% -$22.9K
CYRX icon
88
CryoPort
CYRX
$766M
$5.15M 0.54%
87,081
-323
-0.4% -$22.4K
AVXL icon
89
Anavex Life Sciences
AVXL
$316M
$4.79M 0.51%
276,344
+161
+0.1% +$3.06K
CDXS icon
90
Codexis
CDXS
$175M
$4.77M 0.5%
152,451
-305,860
-67% -$10.1M
MYOV
91
DELISTED
Myovant Sciences Ltd.
MYOV
$4.61M 0.49%
296,166
+3,190
+1% +$60.9K
ATEC icon
92
Alphatec Holdings
ATEC
$1.49B
$4.56M 0.48%
398,655
-970
-0.2% -$11.5K
ALLO icon
93
Allogene Therapeutics
ALLO
$683M
$4.4M 0.46%
294,968
-155,214
-34% -$2.74M
SI
94
DELISTED
Silvergate Capital Corporation
SI
$4.32M 0.46%
29,113
-64,714
-69% -$11.1M
SDGR icon
95
Schrodinger
SDGR
$1.38B
$3.95M 0.42%
113,491
-998
-0.9% -$45.6K
TLS icon
96
Telos
TLS
$324M
$3.68M 0.39%
238,588
-184,492
-44% -$3.93M
WOLF icon
97
Wolfspeed
WOLF
$1.64B
$1.26M 0.13%
11,276
+873
+8% +$97.3K
PODD icon
98
Insulet
PODD
$10.1B
$1.06M 0.11%
3,982
+308
+8% +$89.4K
SEDG icon
99
SolarEdge
SEDG
$1.98B
$942K 0.1%
3,359
+211
+7% +$66.6K
WIX icon
100
WIX.com
WIX
$3.35B
$935K 0.1%
5,924
+1,974
+50% +$342K

Similar funds

Pier Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Pier Capital held 131 positions worth $948M, down 1.7% from $965M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Pier Capital's Q4 2021 filing shows 12 new, 58 increased, 42 reduced and 19 closed positions. Its largest new stake was Fluence Energy: 367,305 shares worth $13.1M. The largest sale was Marten Transport, an estimated $12.1M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.

  • Pier Capital's largest Q4 2021 buy was Fluence Energy: 367,305 shares worth $13.1M.
  • Pier Capital added most to HealthEquity in Q4 2021, an estimated $10.2M increase.
  • Pier Capital's biggest Q4 2021 reduction was Silvergate Capital Corporation, cutting an estimated $11.1M.
  • Pier Capital fully exited Marten Transport in Q4 2021, selling an estimated $12.1M.
  • Pier Capital's ten largest holdings make up 16% of its $948M portfolio in Q4 2021.
  • Pier Capital opened 12 new positions and closed 19 in Q4 2021.
  • Pier Capital's portfolio value fell 1.7% quarter-over-quarter to $948M.

Based on Pier Capital's 13F filing for Q4 2021, filed 10 Feb 2022.